Filter Specialty
Filterspecialty
Submit To The Journals

Education Zone

touchIME is the education division of touchONCOLOGY, we pride ourselves on providing innovative independent learning activities for busy healthcare professionals.

touchSATELLITE SYMPOSIUM Non-Small Cell Lung Cancer (NSCLC)

Watch the footage from our Satellite Symposium at ESMO-IO 2018, with internationally renowned expert faculty discussing the role of immunotherapy in the rapidly evolving treatment paradigm for NSCLC without an oncogenic driver mutation.

Learn More

touchPANEL DISCUSSION Advanced Soft Tissue Sarcoma

Watch a panel of internationally renowned experts discuss the factors influencing the choice of first-line treatment for patients with advanced soft tissue sarcoma and the interpretation of data from clinical trials in this patient population.

Learn More

touchCONGRESS Webinar SABCS 2018

Watch internationally renowned expert, Professor Stephen Johnston, discuss key data in advanced breast cancer presented at the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3–8 December 2018.

Learn More

touchCONGRESS Expert Opinions SABCS 2018

Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the San Antonio Breast Cancer Symposium (SABCS) 2018 Congress, 3-8 December 2018, and what they mean for global and regional clinical practice.

Learn More

touchCONGRESS Webinar ESMO 2018

Watch internationally renowned expert, Dr Javier Cortés, discuss key data in advanced breast cancer presented at the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany.

Learn More

touchCONGRESS Expert Opinions ESMO 2018

Watch leading breast cancer clinicians from Europe and Japan discuss the latest data from the European Society for Medical Oncology (ESMO) 2018 Congress, Munich, Germany, and what they may mean for global and regional clinical practice.

Learn More

touchCONGRESS Expert Forum Advanced Breast Cancer

Watch a group of leading breast cancer specialists debate and discuss how to optimize clinical outcomes for patients with advanced HR+/HER2- disease in the era of CDK4/6 inhibition.

Learn More

touchCONGRESS Webinar ASCO 2018

Watch internationally renowned breast cancer expert, Professor Nadia Harbeck, discuss key data in advanced breast cancer presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, Chicago, USA.

Learn More

touchOPINION BPDCN

Dr. Andrew Lane and Dr. Naveen Pemmaraju discuss the unmet needs for patients with BPDCN and the potential impact of tagraxofusp (SL-401), a novel targeted therapy directed to the interleukin-3 receptor-a(CD123), for improving the clinical outcomes for this aggressive hematological tumor type.

Learn More

touchCONGRESS Expert Opinions ASCO 2018

Watch internationally renowned breast cancer clinicians discussing the latest data from the American Society of Clinical Oncology (ASCO) Annual Meeting 2018, Chicago, IL, US, June 1–5, and what they may mean for clinical practice.

Learn More

touchCONGRESS Webinar AACR 2018

Watch internationally renowned clinical expert, Professor Angelo Di Leo, discuss key data in advanced breast cancer presented at the 2018 American Association for Cancer Research (AACR) Annual Meeting, Chicago, USA.

Learn More

touchFEATURE RRMM

This educationFEATURE on relapsed/refractory multiple myeloma (RRMM) should provide a concise overview of the promising outcomes associated with selinexor, the first-in-class, orally bioavailable, Selective Inhibitor of Nuclear Export (SINE) compound.

Learn More

touchIME

touchIME develops practice changing educational resources that have a positive impact on knowledge transfer with the objective of improving patient outcomes. Our learner first approach ensures these resources are delivered in multiple formats and can be accessed via multiple platforms, including mobile, allowing today’s on-the-go healthcare professionals to enhance their knowledge and skills at a time and in a place that suits them. Our education resources are developed in collaboration with our well established, peer-reviewed medical journals, our Editorial Board members and partnerships with major medical societies, with a clear commitment to high-quality independent education.
Touch IME